Interim analysis demonstrated superior progression-free survival with MeziKd versus carfilzomib/dexamethasone in anti-CD38– and lenalidomide-exposed relapsed ...

The FDA has approved teclistamab (Tecvayli, Janssen Biotech, Inc.) in combination with daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) for the treatment of certain adult ...

(RTTNews) - Halozyme Therapeutics Inc. (HALO) on Friday said Johnson & Johnson has received approval from the U.S. Food and Drug Administration for Tecvayli in combination with Darzalex Faspro to ...

Add Yahoo as a preferred source to see more of our stories on Google. The approval aims to provide a new standard of care and address disease relapse Johnson & Johnson (J&J) has announced the US Food ...

Luka Doncic scores 60 points and LeBron James finishes with a triple-double as the Lakers rally from a 15-point deficit to ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

GDF15 is best known for metabolic effects in managing obesity but has been implicated in nausea experienced by some pregnant women. Data now show how GDF15 attenuates adaptive immunity through a ...

1. Selected dates can't be greater than February 2026. 2. From date can't be greater than To date. 1. Selected dates can't be greater than February 2026. 2. From date can't be greater than To date. 1.

MS is a chronic disease that affects the central nervous system. When you have MS, your immune system attacks the protective sheath (myelin) that covers nerve fibers, and this can lead to ...

What Is It, and Why Does It Matter? The FDA has approved a new combination therapy for treating multiple myeloma in adults in whom the cancer has come back (relapsed) or did not respond to previous ...